People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| i2O Therapeutics, Inc. | — | Biotechnology | Series B | $43.9M | $35.0M | 2019 |
Mitragotri Mitragotri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mitragotri Mitragotri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kurt Graves | 1 | 5 |
| Samir Mitragotri | 1 | 4 |
| Anthony Aiudi | 1 | 4 |
| Katie Ellias | 1 | 3 |
| Ravi Srinivasan | 1 | 3 |
| Christopher Gagliardi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.